Solution provided
Supplier identity
General description

PROGENOSIS is a biotechnology company providing highly tailor-made services ranging from protein design to production and mapping of monoclonal antibodies. We design, study and sell protein domains and biotools that support R&D activities of life sciences companies. We offer also consultancy services, e.g., in antibody development and ELISA based technologies. Our mission is to provide our clients an access to protein domains they have been looking for but never succeeded to approach before.

Type of Supplier
Service Provider - CMO / CROBiotechnology Company - Therapeutics
Sector of activity
  • Cancer / Oncology
  • Drug Discovery / Research & Development
Region of Wallonia, BE
Regional access broker
  • Annick Pierrard, Interface Enterprises-University of Liège
Activity description
The 3 top equipments available

•ProGenosis possesses all the facilities in house, from molecular biology to protein purification; e.g., equipment required for electrophoresis of DNA and protein, but also Biosafety cabinet (Esco Labculture Class II Type A2 Biological Safety Cabinet) and ÄKTA purifier 10. •The laboratory is also well-equipped for ELISA with Microplate Reader (Anthos Multi Read 400) and microplate washer (Anthos Fluido 2). •Moreover, its collaborations with the University of Liège provide a privileged access to the latest laboratory equipment (such as mass spectrometry equipments, SPR (Bioacore),…).

Know-how, expertise available

ProGenosis possess a proprietary technology platform called BHP (Bifunctional Hybrid Protein) from which four related expertise areas have been raised:

  • Protein engineering & expression for difficult-to-express proteins ProGenosis technology enables the easy production of “difficult-to-express” proteins and protein domains.
  • Antigen design & antibody development ProGenosis’ expertise ranges from antigen design to the production of monoclonal antibodies up to grams. The raising of antibodies directed against predefined protein domains are made easier thanks to the ProGenosis approach.
  • Epitope mapping The technology allows the concomitant mapping of linear as well as conformational epitopes in the very same assay.
  • Protein-protein domain interaction We are specialized in the development of biotools for protein interaction.
Quality labels and accreditations

ProGenosis is approved by the French Ministry of Higher Education & Research (MESR) as an organisation carrying out R&D activities for private companies.

Training and Staff possibilities
Contact information
Commercial development manager
Phone number
+32 (0)4 365 40 77
Boulevard du Rectorat, 27b, Building B22, P70c
4000  Liège